Last reviewed · How we verify

NCT07050290

Restoring Segmental Lumbar Lordosis After Failed Previous Fusion at the Same Level

Recruiting now NA Last updated 3 July 2025
What this trial tests

NA trial testing Restoring segmental lordosis at the lumbar spine in Failed Back Surgery Syndrome in 20 participants. Currently enrolling.

Timeline
25 June 2025
Primary endpoint
25 July 2026
25 July 2027

Quick facts

Lead sponsorN.N. Priorov National Medical Research Center of Traumatology and Orthopedics
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date25 June 2025
Primary completion25 July 2026
Estimated completion25 July 2027
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

N.N. Priorov National Medical Research Center of Traumatology and Orthopedics

Who can join

18 and older, any sex, with Failed Back Surgery Syndrome or Degeneration Lumbar Spine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The restoration of lumbar lordosis is mandatory during lumbar fusion surgery for degenerative disc disease, since not restoring lumbar lordosis adequately may adversely affect surgical outcomes and the patient's quality of life in the follow-up. Revision surgery to restore segmental lordosis at the level of previous spinal fusion is extremely difficult to do and its performance is usually inferior to that of primary surgery. Need to provide a surgical technique to restore segmental lordosis via a posterior approach, which is especially important after failed previous fusion at the same lumbar level.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Failed Back Surgery Syndrome

Currently open trials in the same condition.

Other N.N. Priorov National Medical Research Center of Traumatology and Orthopedics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07050290.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing